Table 1.
Clinicopathological characteristics of patient samples and expression of DPT in HCC
| Characteristics | No. of case (%) |
|---|---|
| Age | |
| <50 | 14 (23.3) |
| ≥50 | 46 (76.7) |
| Gender | |
| Male | 49 (81.7) |
| Female | 11 (18.3) |
| Alcoholism | |
| Yes | 16 (26.7) |
| No | 44 (73.3) |
| Liver cirrhosis | |
| Yes | 35 (58.3) |
| No | 25 (41.7) |
| AFP (ng/L) | |
| <200 | 40 (66.7) |
| ≥200 | 20 (33.3) |
| ALT (U/L) | |
| <60 | 42 (70.0) |
| ≥60 | 30 (30.0) |
| AST (U/L) | |
| <40 | 40 (66.7) |
| ≥40 | 20 (33.3) |
| Tumor number | |
| Single | 36 (60.0) |
| Multiple | 24 (40.0) |
| Tumor size | |
| <5cm | 31 (51.7) |
| ≥5cm | 29 (48.3) |
| Portal vein invasion | |
| Yes | 13 (21.7) |
| No | 47 (78.3) |
| TNM stage | |
| I+II stage | 52 (86.7) |
| III+IV stage | 8 (13.3) |
HCC, hepatocellular carcinoma; AFP, α-fetoprotein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TNM, tumor node metastasis.